John George Anson
Directeur Général chez Oxford Gene Technology Ltd.
Profil
John George Anson is currently the Chief Executive Officer & Director at Oxford Gene Technology Ltd.
He is also a Director at Oxford Gene Technology IP Ltd.
and Oxford Gene Technology (Operations) Ltd.
Previously, he held positions as a Director at Cytocell Ltd., Vice President & Head-Product Development at PharmaGenics, Inc., Vice President-Business Development at GE Healthcare Ltd.
(United Kingdom), and Vice President-Business Development at Global Life Sciences Solutions USA LLC.
Dr. Anson holds a doctorate degree from Cranfield University and an undergraduate degree from the University of Kent.
Postes actifs de John George Anson
| Sociétés | Poste | Début |
|---|---|---|
Oxford Gene Technology Ltd.
 Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Directeur Général | 10/04/2018 |
Oxford Gene Technology IP Ltd.
 Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK. | Directeur/Membre du Conseil | - |
Oxford Gene Technology (Operations) Ltd.
 Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999. | Directeur/Membre du Conseil | 23/02/2018 |
Anciens postes connus de John George Anson
| Sociétés | Poste | Fin |
|---|---|---|
Cytocell Ltd.
 Cytocell Ltd. Medical SpecialtiesHealth Technology Cytocell Technologies Ltd. develops medical diagnostic solutions and services. It offers DNA screening solutions for detection of human genetic diseases in cytogenetics and cancer. The company was founded in 1991 by Bruce Savage and is headquartered in Cambridge, UK | Directeur/Membre du Conseil | - |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Corporate Officer/Principal | - |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | - |
Global Life Sciences Solutions USA LLC
 Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a company that manufactures therapeutics. The company is based in Marlborough, MA. | Corporate Officer/Principal | - |
Formation de John George Anson
| Cranfield University | Doctorate Degree |
| University of Kent | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Commercial Services |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a company that manufactures therapeutics. The company is based in Marlborough, MA. | Health Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK. | Health Technology |
Cytocell Ltd.
Cytocell Ltd. Medical SpecialtiesHealth Technology Cytocell Technologies Ltd. develops medical diagnostic solutions and services. It offers DNA screening solutions for detection of human genetic diseases in cytogenetics and cancer. The company was founded in 1991 by Bruce Savage and is headquartered in Cambridge, UK | Health Technology |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999. | Health Technology |
